|
|
DSpace at RU >
Browsing by Author Poortmans, P.M.
Showing results 1 to 6 of 6
| Full Text | Issue Date | Title | Author(s) | | 2010 | Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or younger. | Lammers, E.J.; Huibers, P.; Sangen, M.J. van der; Poll-Franse, L.V. van de; Poortmans, P.M., et al |
| 2009 | Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. | Jones, H.A.; Antonini, N.; Hart, A.A.; Peterse, J.L.; Horiot, J.C., et al |
| 2009 | The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment. | Uwini, S. Al; Antonini, N.; Poortmans, P.M.; Boersma, L.; Hurkmans, C., et al |
| 2008 | Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. | Collette, S.; Collette, L.; Budiharto, T.; Horiot, J.C.; Poortmans, P.M., et al |
| 2008 | The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. | Poortmans, P.M.; Collette, L.; Bartelink, H.; Struikmans, H.; Bogaert, W.F. van den, et al |
| 2007 | Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. | Bartelink, H.; Horiot, J.C.; Poortmans, P.M.; Struikmans, H.; Bogaert, W. van den, et al |
Showing results 1 to 6 of 6
|